Schedule 13D ownership disclosure
Allogene Therapeutics Inc
Common Stock, par value $0.001 per share (the "Common Stock") · CUSIP: 019770106
Event date: 2025-11-06
- Filing-level shares
- 22,032,040.00
- Percent of class
- 9.0%
- Pfizer Inc.Reported CIK 0000078003
Shares: 22,032,040.00 · Class: 9.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000078003-26-000022
- Form type
- SCHEDULE 13D/A
- Filer
- Allogene Therapeutics, Inc.
- CIK
- CIK 1737287
- Filed
- Feb 13, 2026
- Reporting period
- Nov 06, 2025
- Description
- Schedule 13D beneficial ownership